Smruthi Organics [SMRUTHIORG] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

Smruthi Organics

Sun Pharmaceutical
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Smruthi Organics wins in 7 metrics, Sun Pharmaceutical wins in 12 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.
View Metrics Details
Vital Metrics Comparison
Metric | Smruthi Organics | Sun Pharmaceutical | Better |
---|---|---|---|
P/E Ratio (TTM) | 43.19 | 37.73 | Sun Pharmaceutical |
Price-to-Book Ratio | 2.04 | 5.42 | Smruthi Organics |
Debt-to-Equity Ratio | 23.65 | 3.26 | Sun Pharmaceutical |
PEG Ratio | 2.33 | -1.94 | Sun Pharmaceutical |
EV/EBITDA | 13.79 | 23.98 | Smruthi Organics |
Profit Margin (TTM) | 2.88% | 19.29% | Sun Pharmaceutical |
Operating Margin (TTM) | -6.21% | 24.34% | Sun Pharmaceutical |
EBITDA Margin (TTM) | N/A | 24.34% | N/A |
Return on Equity | 4.97% | 15.08% | Sun Pharmaceutical |
Return on Assets (TTM) | 3.19% | 11.87% | Sun Pharmaceutical |
Free Cash Flow (TTM) | $-15.39M | $119.44B | Sun Pharmaceutical |
Dividend Yield | 2.45% | 1.26% | Smruthi Organics |
1-Year Return | -5.31% | -14.60% | Smruthi Organics |
Price-to-Sales Ratio (TTM) | 1.24 | 7.28 | Smruthi Organics |
Enterprise Value | $1.62B | $3,678.87B | Sun Pharmaceutical |
EV/Revenue Ratio | 1.37 | 6.84 | Smruthi Organics |
Gross Profit Margin (TTM) | 53.11% | 79.58% | Sun Pharmaceutical |
Revenue per Share (TTM) | $103 | $224 | Sun Pharmaceutical |
Earnings per Share (Diluted) | $2.96 | $43.23 | Sun Pharmaceutical |
Beta (Stock Volatility) | -0.10 | 0.28 | Smruthi Organics |
Smruthi Organics vs Sun Pharmaceutical Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
Stock | 1D | 1W | 1M | 3M | 6M | YTD |
---|---|---|---|---|---|---|
Smruthi Organics | 3.23% | 2.50% | 16.65% | 3.39% | 10.32% | 6.68% |
Sun Pharmaceutical | -0.31% | 2.80% | 3.33% | -2.89% | -7.84% | -13.69% |
Long-term Returns
Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
---|---|---|---|---|---|---|
Smruthi Organics | -5.31% | -37.90% | 41.21% | -23.44% | -17.38% | 85.03% |
Sun Pharmaceutical | -14.60% | 70.78% | 218.03% | 80.00% | 690.16% | 2,608.73% |
News Based Sentiment: Smruthi Organics vs Sun Pharmaceutical
Smruthi Organics
News based Sentiment: NEGATIVE
Smruthi Organics experienced a significant downturn in September, reporting a loss after three profitable quarters and a substantial revenue decline. This, coupled with regulatory scrutiny and conflicting analyst opinions, creates a concerning picture for investors, making it a pivotal month for the company's trajectory.
Sun Pharmaceutical
News based Sentiment: MIXED
October was a mixed month for Sun Pharma, with a significant acquisition balanced against a decline in net profit. Positive analyst ratings and tariff news provide offsetting positive signals, making it a month of notable, but not overwhelmingly positive, developments for investors.
Performance & Financial Health Analysis: Smruthi Organics vs Sun Pharmaceutical
Metric | SMRUTHIORG | SUNPHARMA |
---|---|---|
Market Information | ||
Market Cap | ₹1.56B | ₹4.01T |
Market Cap Category | Small cap | Large cap |
10 Day Avg. Volume | 4,127 | 3,168,435 |
90 Day Avg. Volume | 13,180 | 2,778,768 |
Last Close | ₹131.00 | ₹1,631.20 |
52 Week Range | ₹103.00 - ₹169.00 | ₹1,548.00 - ₹1,952.25 |
% from 52W High | -22.49% | -16.45% |
All-Time High | ₹419.35 (Jul 12, 2021) | ₹1,960.35 (Sep 30, 2024) |
% from All-Time High | -68.76% | -16.79% |
Growth Metrics | ||
Quarterly Revenue Growth | -0.30% | 0.10% |
Quarterly Earnings Growth | -0.30% | -0.20% |
Financial Health | ||
Profit Margin (TTM) | 0.03% | 0.19% |
Operating Margin (TTM) | -0.06% | 0.24% |
Return on Equity (TTM) | 0.05% | 0.15% |
Debt to Equity (MRQ) | 23.65 | 3.26 |
Cash & Liquidity | ||
Book Value per Share (MRQ) | ₹62.58 | ₹300.99 |
Cash per Share (MRQ) | ₹0.38 | ₹108.88 |
Operating Cash Flow (TTM) | ₹195.06M | ₹110.84B |
Levered Free Cash Flow (TTM) | ₹35.63M | ₹109.29B |
Dividends | ||
Last 12-Month Dividend Yield | 2.45% | 1.26% |
Last 12-Month Dividend | ₹3.00 | ₹21.00 |
Valuation & Enterprise Metrics Analysis: Smruthi Organics vs Sun Pharmaceutical
Metric | SMRUTHIORG | SUNPHARMA |
---|---|---|
Price Ratios | ||
P/E Ratio (TTM) | 43.19 | 37.73 |
Forward P/E | N/A | 49.91 |
PEG Ratio | 2.33 | -1.94 |
Price to Sales (TTM) | 1.24 | 7.28 |
Price to Book (MRQ) | 2.04 | 5.42 |
Market Capitalization | ||
Market Capitalization | ₹1.56B | ₹4.01T |
Enterprise Value | ₹1.62B | ₹3.68T |
Enterprise Value Metrics | ||
Enterprise to Revenue | 1.37 | 6.84 |
Enterprise to EBITDA | 13.79 | 23.98 |
Risk & Other Metrics | ||
Beta | -0.10 | 0.28 |
Book Value per Share (MRQ) | ₹62.58 | ₹300.99 |
Financial Statements Comparison: Smruthi Organics vs Sun Pharmaceutical
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
Metric (MRQ) | SMRUTHIORG | SUNPHARMA |
---|---|---|
Revenue/Sales | ₹189.92M | ₹137.86B |
Cost of Goods Sold | ₹89.06M | ₹28.15B |
Gross Profit | ₹100.86M | ₹109.71B |
Research & Development | N/A | N/A |
Operating Income (EBIT) | ₹-11.79M | ₹33.72B |
EBITDA | ₹3.17M | ₹47.66B |
Pre-Tax Income | ₹-15.53M | ₹31.73B |
Income Tax | ₹-4.58M | ₹8.70B |
Net Income (Profit) | ₹-10.95M | ₹22.93B |
Balance Sheet & Liquidity Metrics (MRQ)
Metric (MRQ) | SMRUTHIORG | SUNPHARMA |
---|---|---|
Cash & Equivalents | ₹4.36M | ₹102.69B |
Total Current Assets | ₹633.33M | ₹526.24B |
Total Current Liabilities | ₹310.76M | ₹181.94B |
Long-Term Debt | ₹81.62M | ₹3.58B |
Total Shareholders Equity | ₹716.29M | ₹724.86B |
Retained Earnings | ₹583.25M | ₹578.62B |
Property, Plant & Equipment | ₹110.00M | ₹100.36B |
Cash Flow Statement Comparison (MRQ)
Metric (MRQ) | SMRUTHIORG | SUNPHARMA |
---|---|---|
Operating Cash Flow | N/A | N/A |
Capital Expenditures | N/A | N/A |
Free Cash Flow | N/A | N/A |
Debt Repayment | N/A | N/A |
Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
Metric | SMRUTHIORG | SUNPHARMA |
---|---|---|
Shares Short | N/A | N/A |
Short Ratio | N/A | N/A |
Short % of Float | N/A | N/A |
Average Daily Volume (10 Day) | 4,127 | 3,168,435 |
Average Daily Volume (90 Day) | 13,180 | 2,778,768 |
Shares Outstanding | 11.45M | 2.40B |
Float Shares | 3.78M | 1.06B |
% Held by Insiders | 0.67% | 0.56% |
% Held by Institutions | 0.00% | 0.25% |
Dividend Analysis & Yield Comparison: Smruthi Organics vs Sun Pharmaceutical
Metric | SMRUTHIORG | SUNPHARMA |
---|---|---|
Last 12-Month Dividend | ₹3.00 | ₹21.00 |
Last 12-Month Dividend Yield | 2.45% | 1.26% |
3-Year Avg Annual Dividend | ₹3.33 | ₹14.67 |
3-Year Avg Dividend Yield | 1.43% | 0.46% |
3-Year Total Dividends | ₹10.00 | ₹44.00 |
Ex-Dividend Date | Jun 13, 2025 | Jul 07, 2025 |